Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-XANTHO in Pressure Ulcer Patients
NCT05199077Phase 2Not yet recruiting
- Sponsor
- Xantho Biotechnology
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of GM-XANTHO in pressure ulcer, sponsored by Xantho Biotechnology. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
GM-XANTHO
03
Conditions
pressure ulcer
Beyond the preview
Go deeper on NCT05199077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199077.